ammonium hydroxide has been researched along with Encephalopathy, Toxic in 21 studies
azane : Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cyclophosphamide caused hyperammonemia; glutamine/ammonia and urea/ammonia ratios in the blood decreased." | 3.78 | Aggravation of cyclophosphamide-induced acute neurological disorders under conditions of artificial acidification of chyme in rats. ( Ivnitsky, JJ; Malakhovsky, VN; Rejuniuk, VL; Schaefer, TV, 2012) |
| "Amiodarone is commonly used in the treatment of refractory paroxysmal atrial fibrillation." | 3.76 | Hepatic dysfunction and neurotoxicity in a patient receiving long-term low-dose amiodarone therapy. ( Arkun, A; Birkhahn, RH; Grau, T; Van Deusen, SK, 2010) |
| "VPA is widely used for the treatment of generalized epilepsy." | 2.61 | [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy]. ( Araki, M; Mukai, T; Naka, H; Shishido, T; Tokinobu, H; Yamada, H, 2019) |
| "Hyperammonemic encephalopathy is a recurrent problem in these patients, and established treatments based on the assumption of liver failure are unsuccessful." | 1.91 | Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma. ( Alwaseem, H; Clark, J; Coffino, P; Heissel, S; Knox, J; Lahasky, R; Levin, SN; Lyons, B; Migler, RD; Molina, H; Requena, D; Shebl, B; Shirani, M; Simon, SM; Surjan, R; Tomasini, MD; Torbenson, MS, 2023) |
| "Methylenedioxymethamphetamine (MDMA) and methcathinone (MCAT) are abused psychostimulant drugs that produce adverse effects in human users that include hepatotoxicity and death." | 1.56 | High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone. ( Chen, Y; Hall, FS; Saber, YH; Tran, HTN, 2020) |
| "Non-neurologic complications included respiratory failure (14 patients, 31." | 1.43 | Initial Serum Ammonia as a Predictor of Neurologic Complications in Patients with Acute Glufosinate Poisoning. ( Cha, K; Cha, YS; Go, J; Hwang, SO; Kim, H; Kim, OH; Kim, TH; Lee, DK; Lee, KH; Youk, H, 2016) |
| " However, a complete reversal of encephalopathy, on withdrawal of the drug, strongly suggested an adverse drug reaction (ADR) due to valproic acid." | 1.40 | Encephalopathy in an infant with infantile spasms: possible role of valproate toxicity. ( Sampath, S; Sivathanu, S; Sunderkumar, S; Veerasamy, M, 2014) |
| " The results show that a binge dosing regimen of METH to the rat increased plasma and brain ammonia concentrations that were paralleled by evidence of hepatotoxicity." | 1.38 | Peripheral ammonia as a mediator of methamphetamine neurotoxicity. ( Halpin, LE; Yamamoto, BK, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, J | 3 |
| Cho, YS | 3 |
| Chun, BJ | 4 |
| Moon, JM | 4 |
| Kim, DK | 3 |
| Lee, BK | 3 |
| Lee, DH | 3 |
| Ryu, SJ | 3 |
| Jung, E | 3 |
| Levin, SN | 1 |
| Tomasini, MD | 1 |
| Knox, J | 1 |
| Shirani, M | 1 |
| Shebl, B | 1 |
| Requena, D | 1 |
| Clark, J | 1 |
| Heissel, S | 1 |
| Alwaseem, H | 1 |
| Surjan, R | 1 |
| Lahasky, R | 1 |
| Molina, H | 1 |
| Torbenson, MS | 1 |
| Lyons, B | 1 |
| Migler, RD | 1 |
| Coffino, P | 1 |
| Simon, SM | 1 |
| Chen, Y | 1 |
| Tran, HTN | 1 |
| Saber, YH | 1 |
| Hall, FS | 1 |
| Marques, PT | 1 |
| Zulfiqar Ali, Q | 1 |
| Selvarajah, A | 1 |
| Faghfoury, H | 1 |
| Wennberg, RA | 1 |
| Andrade, DM | 1 |
| Trigun, SK | 1 |
| Cha, YS | 2 |
| Kim, H | 2 |
| Lee, Y | 1 |
| Choi, EH | 1 |
| Kim, HI | 1 |
| Kim, OH | 2 |
| Cha, KC | 1 |
| Lee, KH | 2 |
| Hwang, SO | 2 |
| Kongsuphon, N | 1 |
| Soukavanitch, M | 1 |
| Teeraaumpornpunt, N | 1 |
| Konmun, J | 1 |
| Ativitavas, T | 1 |
| Ngamphaiboon, N | 1 |
| Yamada, H | 1 |
| Shishido, T | 1 |
| Mukai, T | 1 |
| Araki, M | 1 |
| Naka, H | 1 |
| Tokinobu, H | 1 |
| Sivathanu, S | 1 |
| Sampath, S | 1 |
| Veerasamy, M | 1 |
| Sunderkumar, S | 1 |
| Lee, DK | 1 |
| Youk, H | 1 |
| Go, J | 1 |
| Kim, TH | 1 |
| Cha, K | 1 |
| Arkun, A | 1 |
| Van Deusen, SK | 1 |
| Grau, T | 1 |
| Birkhahn, RH | 1 |
| Laish, I | 1 |
| Ben Ari, Z | 1 |
| Kyong, YY | 1 |
| Choi, KH | 1 |
| Oh, YM | 1 |
| Lee, KU | 1 |
| Halpin, LE | 1 |
| Yamamoto, BK | 1 |
| Schaefer, TV | 1 |
| Rejuniuk, VL | 1 |
| Malakhovsky, VN | 1 |
| Ivnitsky, JJ | 1 |
| Rama Rao, KV | 1 |
| Jayakumar, AR | 1 |
| Norenberg, DM | 1 |
| Latour, P | 1 |
| Biraben, A | 1 |
| Polard, E | 1 |
| Bentué-Ferrer, D | 1 |
| Beauplet, A | 1 |
| Tribut, O | 1 |
| Allain, H | 1 |
| Panda, S | 1 |
| Radhakrishnan, K | 1 |
| Albrecht, J | 1 |
| Wegrzynowicz, M | 1 |
| Solomon, GE | 1 |
4 reviews available for ammonium hydroxide and Encephalopathy, Toxic
| Article | Year |
|---|---|
[Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
Topics: Aged; Ammonia; Anticonvulsants; Biomarkers; Cardiomyopathies; Carnitine; Consciousness Disorders; Ep | 2019 |
Noncirrhotic hyperammonaemic encephalopathy.
Topics: Adult; Ammonia; Biomarkers; Brain Diseases, Metabolic; Early Diagnosis; Humans; Hyperammonemia; Live | 2011 |
Ammonia neurotoxicity: role of the mitochondrial permeability transition.
Topics: Ammonia; Animals; Energy Metabolism; Humans; Mitochondria, Liver; Neurotoxicity Syndromes; Oxidative | 2003 |
Endogenous neuro-protectants in ammonia toxicity in the central nervous system: facts and hypotheses.
Topics: Ammonia; Animals; Antidotes; Excitatory Amino Acid Antagonists; Glutathione; Humans; Hyperammonemia; | 2005 |
17 other studies available for ammonium hydroxide and Encephalopathy, Toxic
| Article | Year |
|---|---|
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
The trend of ammonia levels in patients with glufosinate ammonium poisoning with respect to neurotoxicity.
Topics: Aminobutyrates; Ammonia; Herbicides; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2023 |
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma.
Topics: Ammonia; Brain Diseases; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Neurotoxicity Syndromes | 2023 |
High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone.
Topics: Ammonia; Animals; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Glutamic | 2020 |
Hyperammonemic Encephalopathy Associated with Perampanel: Case Report and Discussion.
Topics: Ammonia; Brain Diseases; Humans; Hyperammonemia; Neurotoxicity Syndromes; Nitriles; Pyridones | 2021 |
Sirtuin-3 activation by honokiol restores mitochondrial dysfunction in the hippocampus of the hepatic encephalopathy rat model of ammonia neurotoxicity.
Topics: Ammonia; Animals; Disease Models, Animal; Hepatic Encephalopathy; Hippocampus; Male; Mitochondria; N | 2021 |
The relationship between serum ammonia level and neurologic complications in patients with acute glufosinate ammonium poisoning: A prospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Aminobutyrates; Ammonia; Female; Herbicides; Humans; Male; Middle Ag | 2018 |
Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib.
Topics: Aged; Ammonia; Anti-Bacterial Agents; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocol | 2019 |
Encephalopathy in an infant with infantile spasms: possible role of valproate toxicity.
Topics: Adrenocorticotropic Hormone; Ammonia; Anticonvulsants; Clonazepam; Drug Therapy, Combination; Female | 2014 |
Serial ammonia measurement in patients poisoned with glufosinate ammonium herbicide.
Topics: Aminobutyrates; Ammonia; Female; Glasgow Coma Scale; Herbicides; Humans; Male; Middle Aged; Neurotox | 2016 |
Initial Serum Ammonia as a Predictor of Neurologic Complications in Patients with Acute Glufosinate Poisoning.
Topics: Adult; Aged; Aged, 80 and over; Aminobutyrates; Ammonia; Emergency Service, Hospital; Female; Glasgo | 2016 |
Hepatic dysfunction and neurotoxicity in a patient receiving long-term low-dose amiodarone therapy.
Topics: Aged, 80 and over; Amiodarone; Ammonia; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemical and Dr | 2010 |
"Hyperammonemia following glufosinate-containing herbicide poisoning: a potential marker of severe neurotoxicity" by Yan-Chido Mao et al., Clin Toxicol (Phila) 2011; 49:48-52.
Topics: Adult; Aged; Aminobutyrates; Ammonia; Biomarkers; Female; Herbicides; Humans; Hyperammonemia; Male; | 2011 |
Peripheral ammonia as a mediator of methamphetamine neurotoxicity.
Topics: Alanine Transaminase; Ammonia; Analysis of Variance; Animals; Aspartate Aminotransferases; Benzodiaz | 2012 |
Aggravation of cyclophosphamide-induced acute neurological disorders under conditions of artificial acidification of chyme in rats.
Topics: Acute Disease; Administration, Oral; Ammonia; Animals; Boric Acids; Cyclophosphamide; Gastric Juice; | 2012 |
Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Drug Interactions; Drug Therapy, Combination; Electroen | 2004 |
Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
Topics: Ammonia; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Female; Fructose; Huma | 2004 |
Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
Topics: Adolescent; Ammonia; Anticonvulsants; Drug Therapy, Combination; Electroencephalography; Female; Fru | 2000 |